1. Home
  2. DTCX vs BNR Comparison

DTCX vs BNR Comparison

Compare DTCX & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Datacentrex Inc. Common Stock

DTCX

Datacentrex Inc. Common Stock

HOLD

Current Price

$2.07

Market Cap

80.7M

Sector

Technology

ML Signal

HOLD

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

HOLD

Current Price

$16.45

Market Cap

126.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DTCX
BNR
Founded
N/A
2014
Country
United States
China
Employees
N/A
N/A
Industry
EDP Services
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
80.7M
126.5M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
DTCX
BNR
Price
$2.07
$16.45
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
286.0K
49.9K
Earning Date
04-13-2026
06-05-2026
Dividend Yield
N/A
N/A
EPS Growth
8.00
N/A
EPS
N/A
N/A
Revenue
$2,446.00
N/A
Revenue This Year
N/A
$111.65
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.51
$6.79
52 Week High
$3.80
$41.72

Technical Indicators

Market Signals
Indicator
DTCX
BNR
Relative Strength Index (RSI) 47.98 73.89
Support Level $1.84 $15.61
Resistance Level $2.27 $18.59
Average True Range (ATR) 0.15 1.38
MACD -0.01 0.46
Stochastic Oscillator 51.21 100.00

Price Performance

Historical Comparison
DTCX
BNR

About DTCX Datacentrex Inc. Common Stock

Datacentrex Inc is a digital infrastructure and capital deployment company that owns and operates Scrypt compute assets and evaluates strategic transactions across asset-backed operating businesses. Its current operating platform is centered on owned and operated Scrypt-based proof-of-work compute deployed through third-party colocation facilities. Datacentrex monetizes this compute through hashrate marketplace mechanisms and manages a treasury of digital assets and cash in a manner intended to preserve capital and support opportunistic, accretive deployment. The company's operations are principally operated remotely at various data centers throughout the United States.

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.

Share on Social Networks: